Telehealth Prescribing
On October 6, 2023, the DEA and HHS announced a second temporary extension of flexibilities for telemedicine prescribing of controlled substances, originally set during the COVID-19 public health emergency. This extension lasts until December 31, 2024.
Compare state policies as you search by state and specific requirements with this resource from the National Telehealth Policy Resource Center.
Details on Utah state legislation regarding telehealth, including links to practice standards for healthcare professionals, payer policies, billing and reimbursement guidelines, and COVID-19-related waivers and temporary changes.
